Unlabelled: The diagnosis of narcolepsy is based on clinical history, sleep studies, and, in some cases, cerebrospinal fluid orexin-A/hypocretin-1 measurement. The gold standard for orexin measurement is the radioimmunoassay but other commercial kits are also available, such as the enzyme immune assay (EIA). The specificity of orexin EIA in humans is unknown. We report four cases where orexin levels were measured by EIA and resulted in false positives and the misdiagnosis of narcolepsy. Therefore, orexin EIA measurement should be strongly discouraged in a clinical setting.
Citation: Sarkanen T, Sved G, Juujärvi M, Alakuijala A, Partinen M. Misdiagnosis of narcolepsy caused by a false-positive orexin-A/hypocretin-1 enzyme immune assay. . 2022;18(8):2075-2078.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340599 | PMC |
| http://dx.doi.org/10.5664/jcsm.10014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epidemiology of narcolepsy and idiopathic hypersomnia in Japan: A retrospective analysis of health insurance claims from the Japan Medical Data Center.
Sleep Med
November 2024
Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Article Synopsis
- Estimation of narcolepsy and idiopathic hypersomnia (IH) prevalence and incidence is difficult due to symptom overlap, underdiagnosis, and misdiagnosis; this study specifically assessed these in Japan.
- The research utilized data from the Japan Medical Data Center, analyzing healthcare claims for over 6 million individuals to estimate point-prevalence as of December 31, 2019, and incidence from 2014-2019.
- Findings showed that narcolepsy had a prevalence of 37.5 per 100,000 and IH had a prevalence of 7.7 per 100,000, with both conditions most common in younger adults aged 20-29.
Patient experiences of narcolepsy and idiopathic hypersomnia in the Nordics: a patient journey map.
J Sleep Res
October 2024
Department of Clinical Neurophysiology, Rigshospitalet, Danish Center for Sleep Medicine, Copenhagen, Denmark.
Central disorders of hypersomnolence (CDH) are chronic diseases that significantly impact the lives of affected individuals. We aimed to explore the perspectives of individuals with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH), and the challenges they encounter in their daily lives and within the healthcare systems in the Nordics. Interviews with patients (N = 41) and healthcare professionals (n = 14) and a patient survey (n = 70) were conducted in 2022 in Denmark, Sweden, Finland, and Norway to develop a patient journey map that visualises the patient with CDH journey and provides insights into the difficulties faced by these individuals.
View Article and Find Full Text PDFAnti-IgLON5 disease with severe central sleep apnea-hypopnea syndrome: A case report.
Heliyon
September 2024
Department of Neurology, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650031, China.
Article Synopsis
- Anti-IgLON5 antibody-related encephalitis is a rare autoimmune disease affecting the central nervous system, with varied clinical symptoms.
- A 73-year-old man was misdiagnosed with narcolepsy but later showed severe respiratory issues, leading to the discovery of anti-IgLON5 antibodies in his tests.
- Effective treatment included using CPAP, immunoglobulin, and corticosteroids, illustrating the importance of recognizing this condition in diagnosing complex sleep disorders.
Knowledge of Narcolepsy Among Physicians in Makkah Region, Saudi Arabia: A Cross-Sectional Study.
Cureus
August 2024
Community Medicine and Health Care, Umm Al-Qura University, Al-Qunfudah, SAU.
Article Synopsis
- The study evaluated physicians' knowledge of narcolepsy in Makkah, Saudi Arabia, using an online questionnaire to collect demographic data and assess their understanding of the disorder.
- Results showed that while 81% of physicians had some awareness of narcolepsy, many lacked knowledge about its onset age, types, and diagnostic criteria, with only 27.4% recognizing specific diagnostic details.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!